Actively Recruiting
Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2022-08-17
2300
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.
CONDITIONS
Official Title
Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 5-16 years
- Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.
You will not qualify if you...
- Children or primary caregivers not providing informed consent to participate
- Children not attending Tulsi Secondary Boarding School in Tulsipur.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tulsi Secondary Boarding School
Tulsi̇̄pur, Nepal, 22412
Actively Recruiting
Research Team
T
Thomas Pilgrim, Prof. Dr.
CONTACT
K
Krishna Agrawal, Prof. Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here